NCT04920396

Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction

• Status: Suspended
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Aston University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the effectiveness of E\>EYE intense regulated pulsed light (IRPL) treatment compared to the current standard of care using a daily warm compress

Detailed description

E-Eye is a medical device that has been specifically designed for treating dry eye syndrome due to meibomian gland dysfunction (MGD). This study is a prospective, single centred, interventional, randomized study assessing the efficacy and safety of E\>EYE in the management of MGD (3 applications on days 0, 15 and 45, with a follow up 1 month later) compared to daily use of a warm compress over a period of 75 days. The study will monitor the change in symptoms and signs of dry eye at each visit.)

Conditions

• Meibomian Gland Dysfunction

Interventions

Type	Name	Description
DEVICE	E>Eye IRPL	Regulated intense pulsed light therapy
DEVICE	Warm compress	Fabric mask with anti-bacterial coating filled with BodyBeads® heated in a microwave for 30 seconds before application over the eyes for 5 minutes

Timeline

• Start date: 2021-06-08
• Primary completion: 2026-02-16
• Completion: 2026-12-16
• First posted: 2021-06-09
• Last updated: 2024-04-23

Locations

1 site across 1 country: Canada